Reimbursement
Is your device CE marked but you are struggling to increase sales?
Do you understand the reimbursement mechanism in the UK?
What is the Drug Tariff?
Do you need help gaining reimbursement in Germany?
We note that (unlike medical device regulation) there is no pan-European process for medical device reimbursement. Most countries use a system of diagnosis related groups (DRGs) to set a price for a particular medical procedure (including any products that will be used in that procedure). The authorities use health technology assessment (HTA) to decide which products will be formally approved for use in the procedure, ensuring that only those products shown to be clinically and economically effective are reimbursed. However, the decision concerning which products will be reimbursed (and often also what price will be paid) by the government or patient’s health insurance provider is driven by local government health care policy. As such, there can be considerable variation in the reimbursement approval process (and data requirements) between different countries. Additionally, the processes can be subject to regular change, as countries reform their respective health-care systems and budgets in line with their current policies.
We have experience of the reimbursement systems in the following countries:
- United Kingdom & Republic of Ireland
- France
- Germany
- Italy
- Spain
- Belgium
- Holland
- Switzerland
- Austria
- Greece*
- Nordic region – Norway, Sweden, Finland*
- Central and Eastern Europe – Czech Republic and Poland*
* Note: We do not have personnel with a native language capability in these countries.
